UNSPSC 85253605: Diagnosis of carcinoma in situ on the prostate

This classification denotes the group of activities that yields a diagnosis of Carcinoma in situ on the Prostate. Carcinoma in situ on the Prostate is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D07. 5

UNSPSC 85253605 Diagnosis of carcinoma in situ on the prostate is a Commodity code that shows limited alignment with actual state and local procurement activity. The three recent opportunities posted under this code — a diagnostic imaging PACS system for San Mateo Medical Center, special education contracted services for Birdville Independent School District, and temporary health professional staffing for Santa Clara County Health System — address clinical support services and workforce augmentation rather than prostate cancer screening or diagnostic pathology work. The code's nominal scope (prostate carcinoma diagnosis) does not match the health system procurement currently tagged to it, suggesting either upstream classification drift or misalignment between the UNSPSC taxonomy and how issuing bodies categorize clinical services.

The recent activity spans two states — California (San Mateo County and Santa Clara County health systems) and Texas (Birdville Independent School District in Tarrant County) — with no discernible geographic concentration. San Mateo Medical Center posted an RFP for Diagnostic Imaging PACS with proposals due October 21, 2026, seeking an enterprise-grade picture archiving system supporting radiology, cardiology, and dental imaging integrated with EPIC, with a five-year agreement term and $17.00 per hour minimum wage compliance required. Santa Clara County Health System opened qualification submissions (due October 7, 2026) for a non-exclusive, multiple-award qualified vendor pool covering 13 ancillary clinical categories including diagnostic imaging and therapy services, with no guaranteed work volume. The code shows no clearly relevant recent opportunities; buyers looking to pursue prostate diagnostics or cancer-screening work should verify actual UNSPSC classification directly with issuing bodies rather than relying on this code's current tagging pattern.